• Health & Medicine

Cervical cancer progress falters as screening uptake hits record lows

Cervical cancer rates in Britain halved between the late 1980s and mid-2000s - but new CRUK figures warn that progress has since been stalling and stagnating. Cervical cancer rates in Britain halved between the late 1980s and mid-2000s - but new CRUK figures warn that progress has since been stalling and stagnating.

22 January 2020

• Science & Technology

Magnetised molecules used to monitor breast cancer

Scientists have tested a new type of scan, which reveals how aggressive a tumour is, for the first time in patients with breast cancer. Scientists have tested a new type of scan, which reveals how aggressive a tumour is, for the first time in patients with breast cancer.

20 January 2020

• Health & Medicine

Hormone therapy now available for newly diagnosed prostate cancer in Scotland 

A hormone therapy has been approved for NHS use in Scotland for some people with newly diagnosed, advanced prostate cancer for the first time.   A hormone therapy has been approved for NHS use in Scotland for some people with newly diagnosed, advanced prostate cancer for the first time.  

20 January 2020

• Health & Medicine

New breed of targeted cancer drug gets initial ‘no’ for NHS in England  

A targeted drug, larotrectinib (Vitrakvi), will not be made an option for adults and children whose tumours test positive for a specific genetic change. A targeted drug, larotrectinib (Vitrakvi), will not be made an option for adults and children whose tumours test positive for a specific genetic change.

15 January 2020

• Health & Medicine

Lung cancer immunotherapy gets initial ‘no’ for NHS in England

An immunotherapy and chemotherapy combo has been rejected for some adults with small cell lung cancer on the NHS in England. An immunotherapy and chemotherapy combo has been rejected for some adults with small cell lung cancer on the NHS in England.

8 January 2020

• Health & Medicine

Complex innovative trials: Authors call for new guideline adoption to get medicines to patients faster

Complex Innovative Design trials could be transformed for the better, following the publication of ten recommendations in the British Journal of Cancer. Complex Innovative Design trials could be transformed for the better, following the publication of ten recommendations in the British Journal of Cancer.

6 January 2020

• Science & Technology

First-in-human trial for new lung cancer immunotherapy

Cancer Research UK and VOLT, announce a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lung cancer Cancer Research UK and VOLT, announce a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lung cancer

17 December 2019

• Health & Medicine

Blood test can quickly match advanced breast cancer patients to targeted treatments

New trial results show that a blood test can identify rare types of advanced breast cancer and help patients to access the right treatment more quickly. New trial results show that a blood test can identify rare types of advanced breast cancer and help patients to access the right treatment more quickly.

12 December 2019

• Health & Medicine

Targeted ovarian cancer drug made available to more people on NHS in England

NICE has made olaparib (Lynparza), a targeted cancer drug, more widely available for people with ovarian cancer on the NHS in England. NICE has made olaparib (Lynparza), a targeted cancer drug, more widely available for people with ovarian cancer on the NHS in England.

11 December 2019

• Health & Medicine

Targeted ovarian cancer drug made more widely available on the NHS in Scotland

A targeted cancer drug has been approved for use on the NHS in Scotland for patients with newly diagnosed ovarian cancer that’s responded to chemotherapy. A targeted cancer drug has been approved for use on the NHS in Scotland for patients with newly diagnosed ovarian cancer that’s responded to chemotherapy.

9 December 2019

• Science & Technology

So-called 'junk DNA' affects inherited cancer risk

Research reveals how genetic variations in the regions of DNA that don't code for proteins, once dismissed as 'junk DNA', can affect a person's risk of cancer. Research reveals how genetic variations in the regions of DNA that don't code for proteins, once dismissed as 'junk DNA', can affect a person's risk of cancer.

6 December 2019

• Health & Medicine

A quarter of cancer patients experience avoidable delay to diagnosis

One in four cancer patients experienced a delay to their diagnosis that could have been avoided. One in four cancer patients experienced a delay to their diagnosis that could have been avoided.

4 December 2019